http://www.coldchainiq.com/regulatory-resources/white-papers/a-one-page-guide-to-global-gdp-guidelines/
All GDP guidelines in one single place!
Good Distribution Practice (GDP) is the part of quality assurance which ensures that products are consistently stored, transported and handled under suitable condition as required by the marketing authorisation (MA) or product specification. There is no single global GDP standard. Cold Chain IQ has created this easy to-assimilate summary of GDP requirements around the world, enabling you to navigate the landscape. You can keep it as a handy reference, share it around your colleagues or even stick it on your wall!
Leading Practices for Distribution SuccessNet at Work
As the pace of change in business accelerates—especially for those still relying on aged, on-premise ERP systems, wholesale distributors are struggling to keep up. Today’s leading distribution businesses need a proven solution that can be deployed quickly, predictably, and affordably, setting you up for growth and success.
The purpose of Gap Analysis is to assist pharmaceutical manufacturers, distributors or 3 PLs (3rd Party Logistics Providers) to help them identify gaps in their cold chain supply chain network or systems.
What you will learn:
* The regulatory aspects related to the cold chain
* Responsibilities in the supply chain
* Requirements for the storage and handling of drug products
* Packaging, transportation and distribution of drug products
* Performing a gap analysis to know what needs to be done in order to fully comply with regulations and optimize your processes
* Ways and means to develop an executable action plan
How you will benefit:
* Understand how to execute a cold chain regulatory gap analysis
* Discover what should be covered when looking at cold chain compliance
* Gap analysis: The first step to develop a cold chain compliance program
* Uncover the requirements for the storage and distribution of drug products
* Sharing the responsibilities for a good cold chain compliance
Leading Practices for Distribution SuccessNet at Work
As the pace of change in business accelerates—especially for those still relying on aged, on-premise ERP systems, wholesale distributors are struggling to keep up. Today’s leading distribution businesses need a proven solution that can be deployed quickly, predictably, and affordably, setting you up for growth and success.
The purpose of Gap Analysis is to assist pharmaceutical manufacturers, distributors or 3 PLs (3rd Party Logistics Providers) to help them identify gaps in their cold chain supply chain network or systems.
What you will learn:
* The regulatory aspects related to the cold chain
* Responsibilities in the supply chain
* Requirements for the storage and handling of drug products
* Packaging, transportation and distribution of drug products
* Performing a gap analysis to know what needs to be done in order to fully comply with regulations and optimize your processes
* Ways and means to develop an executable action plan
How you will benefit:
* Understand how to execute a cold chain regulatory gap analysis
* Discover what should be covered when looking at cold chain compliance
* Gap analysis: The first step to develop a cold chain compliance program
* Uncover the requirements for the storage and distribution of drug products
* Sharing the responsibilities for a good cold chain compliance
Marv Shepherd, PSM president, Member USP Package Storage and Distribution Expert Committee, and Professor at the University of Texas at Austin speaks about updates to United States Pharmacopeia's good distribution practices.
The European Commission Health and Consumers Directorate – General has published a draft “GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICES FOR ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE”.
The guideline addresses Quality systems, Personnel, Documentation, Order, Procedures, Records, Premises and Equipment, Receipts, Storage , Deliveries to Customers, Transfer of Information and Returns.
Following presentation is prepared by “ Drug Regulations” a non profit organization which provides free online resource to the Pharmaceutical Professional.
GDP và tầm quan trọng của việc theo dõi nhiệt độ.
Chuỗi cung cấp các sản phẩm thuốc và các hoạt chất rất phức tạp. Chuỗi cung ứng hoàn chỉnh - từ việc sản xuất API và tá dược đến cung cấp các sản phẩm hoàn chỉnh - phải được ghi lại và kiểm soát. Một trong những tiêu chí quan trọng cần được giám sát là nhiệt độ.
Xem thêm các tài liệu khác trên kênh của Công ty Cổ phần Tư vấn Thiết kế GMP EU.
Environmental regulations are becoming more consistent globally, as those passed in one region have knock-on effects on supply chains in other regions. Companies across many sectors, especially those in fast moving consumer goods and food & beverage, are under pressure to publish sustainability reports and enforce environmental standards. This GIA whitepaper outlines sustainable practices in the manufacturing and logistics industries, and the role of sustainability in the Asia-Pacific.
This presentation shows selected slides from a GIA white paper. To download the entire white paper that you are interested in, please visit http://bit.ly/GIAinsightWP
Risk reduction in tablet dosage form development and manufacturingDipankar Dey
This article describes how measuring material properties that
relate directly to the final tablet product, including the inherent
ability of materials to form tablets (compressibility) reduces the
overall risk in tablet development and manufacture. A case
study illustrates the benefits of rapid compressibility assessment.
Marv Shepherd, PSM president, Member USP Package Storage and Distribution Expert Committee, and Professor at the University of Texas at Austin speaks about updates to United States Pharmacopeia's good distribution practices.
The European Commission Health and Consumers Directorate – General has published a draft “GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICES FOR ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE”.
The guideline addresses Quality systems, Personnel, Documentation, Order, Procedures, Records, Premises and Equipment, Receipts, Storage , Deliveries to Customers, Transfer of Information and Returns.
Following presentation is prepared by “ Drug Regulations” a non profit organization which provides free online resource to the Pharmaceutical Professional.
GDP và tầm quan trọng của việc theo dõi nhiệt độ.
Chuỗi cung cấp các sản phẩm thuốc và các hoạt chất rất phức tạp. Chuỗi cung ứng hoàn chỉnh - từ việc sản xuất API và tá dược đến cung cấp các sản phẩm hoàn chỉnh - phải được ghi lại và kiểm soát. Một trong những tiêu chí quan trọng cần được giám sát là nhiệt độ.
Xem thêm các tài liệu khác trên kênh của Công ty Cổ phần Tư vấn Thiết kế GMP EU.
Environmental regulations are becoming more consistent globally, as those passed in one region have knock-on effects on supply chains in other regions. Companies across many sectors, especially those in fast moving consumer goods and food & beverage, are under pressure to publish sustainability reports and enforce environmental standards. This GIA whitepaper outlines sustainable practices in the manufacturing and logistics industries, and the role of sustainability in the Asia-Pacific.
This presentation shows selected slides from a GIA white paper. To download the entire white paper that you are interested in, please visit http://bit.ly/GIAinsightWP
Risk reduction in tablet dosage form development and manufacturingDipankar Dey
This article describes how measuring material properties that
relate directly to the final tablet product, including the inherent
ability of materials to form tablets (compressibility) reduces the
overall risk in tablet development and manufacture. A case
study illustrates the benefits of rapid compressibility assessment.
Cold Chain IQ Celebrates its 1st Anniversary: InfographicPharma IQ
[www.ColdChainIQ.com] Industry website Cold Chain IQ www.coldchainiq.com is celebrating its 1st Anniversary after it was rebranded from Pharma IQ to better serve professionals involved in the storage and distribution of tempearture-sensitive life science products.
It’s Been A Busy Year Since Our Website Launch in April 2012. Find Out What We Have Been Up To…
The 7 Deadly Sins of Quality Assurance and Quality Control - Pharma IQ eBookPharma IQ
The Seven Sins of QA and QC are those transgressions which are detrimental to quality and profitability. You will probably commit some of them every day. We asked the global pharmaceutical community what they thought were the biggest sins that people commit in quality assurance and quality control and the same ones kept coming up over and over again.
2nd Annual Bioequivalence and Bioavailability Studies 2011 - AgendaPharma IQ
2nd Annual Bioequivalence and Bioavailability Studies - Full Agenda
LEARN MORE
http://www.bioequivalenceevent.com/redForms.aspx?id=532198&pdf_form=1?&shownewswindow=1&utm_source=PharmaIQ&utm_medium=SMO&mac=PMIQ_Slideshare&utm_campaign=Slideshare&utm_term=pdf
Developing IP Strategies for Crystalline Forms 2011 - AgendaPharma IQ
7th Annual Developing IP Strategies for Crystalline Forms - View the full agenda
LEARN MORE
http://www.ipcrys.com/redForms.aspx?id=545786&pdf_form=1?&shownewswindow=1&utm_source=PharmaIQ&utm_medium=SMO&mac=PMIQ_Slideshare&utm_campaign=Slideshare&utm_term=pdf
Single Use & Disposable Technology in BiomanufacturingPharma IQ
Single Use & Disposable Technology in Biomanufacturing
Pharma IQ Sector Report & Resources June 2011
Downloadable guide to latest developments in this field
LEARN MORE
https://www.disposablebiomanufacturingonline.com/?&shownewswindow=1&utm_source=PharmaIQ&utm_medium=SMO&mac=PMIQ_Slideshare&utm_campaign=Slideshare&utm_term=pdf
Opportunities with Pharma IQ - the Network for Pharma and Biotech Professionals
= Engage with a Global Pharma Community
= Position yourself as a Pharma Business Leader
= Achieve Unparalleled Campaign Results
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdfPaige Cruz
Monitoring and observability aren’t traditionally found in software curriculums and many of us cobble this knowledge together from whatever vendor or ecosystem we were first introduced to and whatever is a part of your current company’s observability stack.
While the dev and ops silo continues to crumble….many organizations still relegate monitoring & observability as the purview of ops, infra and SRE teams. This is a mistake - achieving a highly observable system requires collaboration up and down the stack.
I, a former op, would like to extend an invitation to all application developers to join the observability party will share these foundational concepts to build on:
Generative AI Deep Dive: Advancing from Proof of Concept to ProductionAggregage
Join Maher Hanafi, VP of Engineering at Betterworks, in this new session where he'll share a practical framework to transform Gen AI prototypes into impactful products! He'll delve into the complexities of data collection and management, model selection and optimization, and ensuring security, scalability, and responsible use.
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...UiPathCommunity
💥 Speed, accuracy, and scaling – discover the superpowers of GenAI in action with UiPath Document Understanding and Communications Mining™:
See how to accelerate model training and optimize model performance with active learning
Learn about the latest enhancements to out-of-the-box document processing – with little to no training required
Get an exclusive demo of the new family of UiPath LLMs – GenAI models specialized for processing different types of documents and messages
This is a hands-on session specifically designed for automation developers and AI enthusiasts seeking to enhance their knowledge in leveraging the latest intelligent document processing capabilities offered by UiPath.
Speakers:
👨🏫 Andras Palfi, Senior Product Manager, UiPath
👩🏫 Lenka Dulovicova, Product Program Manager, UiPath
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...DanBrown980551
Do you want to learn how to model and simulate an electrical network from scratch in under an hour?
Then welcome to this PowSyBl workshop, hosted by Rte, the French Transmission System Operator (TSO)!
During the webinar, you will discover the PowSyBl ecosystem as well as handle and study an electrical network through an interactive Python notebook.
PowSyBl is an open source project hosted by LF Energy, which offers a comprehensive set of features for electrical grid modelling and simulation. Among other advanced features, PowSyBl provides:
- A fully editable and extendable library for grid component modelling;
- Visualization tools to display your network;
- Grid simulation tools, such as power flows, security analyses (with or without remedial actions) and sensitivity analyses;
The framework is mostly written in Java, with a Python binding so that Python developers can access PowSyBl functionalities as well.
What you will learn during the webinar:
- For beginners: discover PowSyBl's functionalities through a quick general presentation and the notebook, without needing any expert coding skills;
- For advanced developers: master the skills to efficiently apply PowSyBl functionalities to your real-world scenarios.
State of ICS and IoT Cyber Threat Landscape Report 2024 previewPrayukth K V
The IoT and OT threat landscape report has been prepared by the Threat Research Team at Sectrio using data from Sectrio, cyber threat intelligence farming facilities spread across over 85 cities around the world. In addition, Sectrio also runs AI-based advanced threat and payload engagement facilities that serve as sinks to attract and engage sophisticated threat actors, and newer malware including new variants and latent threats that are at an earlier stage of development.
The latest edition of the OT/ICS and IoT security Threat Landscape Report 2024 also covers:
State of global ICS asset and network exposure
Sectoral targets and attacks as well as the cost of ransom
Global APT activity, AI usage, actor and tactic profiles, and implications
Rise in volumes of AI-powered cyberattacks
Major cyber events in 2024
Malware and malicious payload trends
Cyberattack types and targets
Vulnerability exploit attempts on CVEs
Attacks on counties – USA
Expansion of bot farms – how, where, and why
In-depth analysis of the cyber threat landscape across North America, South America, Europe, APAC, and the Middle East
Why are attacks on smart factories rising?
Cyber risk predictions
Axis of attacks – Europe
Systemic attacks in the Middle East
Download the full report from here:
https://sectrio.com/resources/ot-threat-landscape-reports/sectrio-releases-ot-ics-and-iot-security-threat-landscape-report-2024/
Essentials of Automations: Optimizing FME Workflows with ParametersSafe Software
Are you looking to streamline your workflows and boost your projects’ efficiency? Do you find yourself searching for ways to add flexibility and control over your FME workflows? If so, you’re in the right place.
Join us for an insightful dive into the world of FME parameters, a critical element in optimizing workflow efficiency. This webinar marks the beginning of our three-part “Essentials of Automation” series. This first webinar is designed to equip you with the knowledge and skills to utilize parameters effectively: enhancing the flexibility, maintainability, and user control of your FME projects.
Here’s what you’ll gain:
- Essentials of FME Parameters: Understand the pivotal role of parameters, including Reader/Writer, Transformer, User, and FME Flow categories. Discover how they are the key to unlocking automation and optimization within your workflows.
- Practical Applications in FME Form: Delve into key user parameter types including choice, connections, and file URLs. Allow users to control how a workflow runs, making your workflows more reusable. Learn to import values and deliver the best user experience for your workflows while enhancing accuracy.
- Optimization Strategies in FME Flow: Explore the creation and strategic deployment of parameters in FME Flow, including the use of deployment and geometry parameters, to maximize workflow efficiency.
- Pro Tips for Success: Gain insights on parameterizing connections and leveraging new features like Conditional Visibility for clarity and simplicity.
We’ll wrap up with a glimpse into future webinars, followed by a Q&A session to address your specific questions surrounding this topic.
Don’t miss this opportunity to elevate your FME expertise and drive your projects to new heights of efficiency.
Epistemic Interaction - tuning interfaces to provide information for AI supportAlan Dix
Paper presented at SYNERGY workshop at AVI 2024, Genoa, Italy. 3rd June 2024
https://alandix.com/academic/papers/synergy2024-epistemic/
As machine learning integrates deeper into human-computer interactions, the concept of epistemic interaction emerges, aiming to refine these interactions to enhance system adaptability. This approach encourages minor, intentional adjustments in user behaviour to enrich the data available for system learning. This paper introduces epistemic interaction within the context of human-system communication, illustrating how deliberate interaction design can improve system understanding and adaptation. Through concrete examples, we demonstrate the potential of epistemic interaction to significantly advance human-computer interaction by leveraging intuitive human communication strategies to inform system design and functionality, offering a novel pathway for enriching user-system engagements.
Securing your Kubernetes cluster_ a step-by-step guide to success !KatiaHIMEUR1
Today, after several years of existence, an extremely active community and an ultra-dynamic ecosystem, Kubernetes has established itself as the de facto standard in container orchestration. Thanks to a wide range of managed services, it has never been so easy to set up a ready-to-use Kubernetes cluster.
However, this ease of use means that the subject of security in Kubernetes is often left for later, or even neglected. This exposes companies to significant risks.
In this talk, I'll show you step-by-step how to secure your Kubernetes cluster for greater peace of mind and reliability.
Securing your Kubernetes cluster_ a step-by-step guide to success !
[Infographic] A One Page Guide to Global GDP Guidelines
1. www.coldchainiq.com
A One Page Good Distribution Practice (GDP) is the part of quality
assurance which ensures that products are consistently
Guide to
stored, transported and handled under suitable IATA v
condition as required by the marketing authorisation r Chapter 17 “Air Transport Logistics for
Time and Temperature Sensitive
(MA) or product specification. There is no single global
Global GDP
Healthcare Products”
GDP standard. Cold Chain IQ has created this easy- IATA Perishable Cargo Regulations (PCR)
to-assimilate summary of GDP requirements around
Guidelines the world, enabling you to navigate the landscape. You
can keep it as a handy reference, share it around your
colleagues or even stick it on your wall!
european commission
r Commission Guidelines on Good
Distribution Practice of Medicinal Products
china
r Coming Soon: The newly revised Good
Supply Practice for Pharmaceutical
Products (GSP) will go into effect as of
for Human Use, 2011
r Guidelines on Good Distribution Practice June 1, 2013
KEy of Medicinal Products for Human Use State Food and Drug Administration, P.R.
uk r The principles of GDP are stated in China (SFDA)
Cick for more information r Guidance in the Transportation of Medicinal Directive 92/25/EEC
Products, ambient and refrigerated European Medicines Agency (EMA)
Medicines and Healthcare products
Regulatory Agency (MHRA)
canada
r Guidelines for Temperature Control of
denmark
r Executive Order No. 823 (IDRAC
Drug Products during Storage and ireland 148449): Distribution of Medicinal India
Transportation (GUI-0069) r IMB - Medicinal Products (Prescription Products, August 2012 r Guidelines on Good Distribution
Health Canada and Control of Supply) (Amendment) Danish Health and Medicines Agency Practices for Biological Products
Regulations 2007 (SI 201 of 2007)
r DRAFT: Guidelines on Good Distribution
r IMB Guide to Control and Monitoring of
united states Storage and Transportation Temperature
Practices for Pharmaceutical Products
Central Drugs Standard Control
r USP General Chapter <1079> Good
Storage and Shipping Practices
Conditions for Medical Products and
Active Substance
Worldwide Organization (CDSCO)
WHO v
r USP General Chapter <1083> Good Irish Medicines Board (IMB) r Good Distribution Practices for
Distribution Practices—Supply Chain pharmaceutical products TRS No. 957,
Integrity Annex 5 (2010)
United States Pharmacopeia (USP) r Model requirements for the storage and
transport of time and tem-perature
sensitive pharmaceutical products TRS singapore
No. 961, Annex 9 (2011) r DRAFT Guidance notes on Good
World Health Organization (WHO) Distribution Practice
Health Sciences Authority (HSA)
Brazil IPEC Europe v
r Opens public consultation on GMP r The IPEC –Europe Good Distribution
and GDP Requirements on January 15. Practices Audit Guideline FOR
Deadline for comments March 12, 2013 PHARMACEUTICAL EXCIPIENTS 2011
The National Health Surveillance Agency International Pharmaceutical Excipients
(Anvisa) Council (IPEC)
PDA v
Argentina r PDA Technical Report TR 52 (Aug 2011)
r ANMAT Ley 26.492, Regulación
Guidance for Good Distribution Practices
(GDPs) for the Pharmaceutical Supply
Australia
de la cadena de frío de los r Australian code of good wholesaling
Chain
medicamentos, 2009 practice for therapeutic goods for
r PDA Technical Report TR 53 Guidance
National Administration of Drugs, Foods human use
for Industry: Stability Testing to Support
and Medical Devices (ANMAT) Therapeutic Goods Administration (TGA)
Distribution of New Drug Products
r PDA Technical Report TR 58 Risk
Management for Temperature-
This information is accurate to the best of the respondents knowledge at that time, and may subsequently have changed. Cold Chain Controlled Distribution
IQ cannot take responsibility for the accuracy of this information. Reference: David Ulrich presentation “Good Distribution Practices Parenteral Drug Association(PDA) Connect to a cold chain
(GDP‘s) & Pharma Supply Chain Management” at the 2011 PDA Pharmaceutical Cold Chain Management Conference. IQ social network